The two groups differed significantly for sex, diabetes duration, baseline BMI, HbA1c, lipids, prevalence of macroangiopathy, comorbidity index and therapy with DPP-4 inhibitors, statins and anti-platelet agents (Table 1). This evidence concerns the gene DPP4 and diabetes mellitus.